• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 80 of 100
DNA genetic testing (crop)
Health
GlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
Makers Took Big Price Increases on Widely Used U.S. Drugs
Health
Makers Took Big Price Increases on Widely Used U.S. Drugs
By ReutersApril 4, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health
Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health
Novartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
Doctors Without Borders Protests High Cost Of Vaccines
Finance
Pfizer Just Got Pranked Big Time Before April Fool’s Day Even Started
By Jen WiecznerMarch 31, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Bill Ackman Can’t Sell Valeant Even If He Wants To
By Lucinda ShenMarch 31, 2016
483106863
Health
GlaxoSmithKline Is Expanding Drug Access to the World’s Poorest Countries
By Sy MukherjeeMarch 31, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By ReutersMarch 31, 2016
RU486
Health
FDA Enters the Abortion Debate Fray With Latest Decision
By Laura LorenzettiMarch 30, 2016
BRITAIN-PHARMACEUTICAL-GSK
Health
Here’s How GlaxoSmithKline’s CEO Thinks Pharma Should Modernize
By Sy MukherjeeMarch 30, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance
Valeant Is Asking its Lenders for More Time to File its Annual Report
By ReutersMarch 30, 2016
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
Health
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
By ReutersMarch 29, 2016
503920324
Finance
Why Acadia Pharma’s Shares Are Popping Today
By Sy MukherjeeMarch 28, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Valeant’s CEO Will Have to Testify at a U.S. Congressional Hearing
By ReutersMarch 28, 2016
Woman With Headache
Health
Here’s Why Alder Pharmaceutical’s Stock Is Booming
By Laura LorenzettiMarch 28, 2016
1...
  • 78
  • 79
  • 80
  • 81
  • 82
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.